Caflx

Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer

Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure

SANOMA CORPORATION: ACQUISITION OF OWN SHARES 13 March 2026

Campbell’s Appoints Joshua Levine Chief Investor Relations Officer

Tocvan Partners With VRIFY to Accelerate Exploration and Enhance Discovery Potential With AI at Gran Pilar